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Virulence, secretion, bacterial competition, VgrG, Tle 49 50 Introduction further entry of P. aeruginosa [12] . The evolved VgrG2b effector [26] is delivered by H2-113 T6SS into epithelial cells where it targets the γ-tubulin ring complex, a microtubule-114 nucleating multiprotein complex to promote a microtubule-dependent internalization of P. 115 aeruginosa. Finally TplE (Tle4), which is secreted by the H2-T6SS machinery, promotes 116 autophagy in epithelial cells once localized to the endoplasmic reticulum [13] . Interestingly 117 PldA (Tle5a), PldB (Tle5b) and TplE (Tle4) have also been identified as antibacterial 118 phospholipases of the Tle (type VI lipase effectors) family [11] . They work by affecting 119 membrane integrity of the rival bacteria [11] [12] [13] . More precisely, PldA degrades the major 120 constituent of bacterial membranes, the phosphatidylethanolamine [11] . 121
In the present study we have discovered a novel antibacterial toxin, Tle3 and its 122 cognate immunity, Tli3, whose genes are encoded downstream of vrgG2b. By characterizing 123 the secretion mechanism of Tle3 by H2-T6SS, we showed that it requires Tla3, a cytoplasmic 124 adaptor of a unique family, to be targeted to the VgrG2b spike. Interestingly we also found 125 that the C-terminal extension of VgrG2b is toxic towards Escherichia coli making VgrG2b a 126 new trans-kingdom effector of P. aeruginosa. 127
128

Results
129
Tle3 is a novel antibacterial toxin of P. aeruginosa 130 comparisons of PA0259 and PA0261 showed that PA0261 is homologous to Tsi6, the 138 immunity protein of a H1-T6SS effector called Tse6, and PA0259 to TplEi (Tli4), the 139 immunity of TlpE (Tle4), a H2-T6SS effector [13, 30] . We used the SignalP 4.1 server [31] to 140 predict the cellular localization of the two immunity candidates. While a Sec signal sequence 141 is predicted at the N-terminal extremity of PA0261, the analysis of the PA0259 sequence did 142 not reveal any. However three upstream ATG can be found in frame with the annotated ATG 143 of PA0259 ( Fig. 1 sup) . The sequence of the proteins synthesized from the two first ATG 144 (ATG1 et ATG2) presents then a N-terminal signal peptide, while the protein synthesized from 145 the last codon (ATG3) does not. Moreover a RBS (Ribosome Binding Sequence) can be found 146 only upstream of ATG1 and with a significant Kolaskar score that indicates a strong 147 probability to be used as an initiation codon [32] . Altogether these data tend to indicate an 148 incorrect annotation of the start codon of PA0259 and that ATG1 should be considered for the 149 initiation of PA0259 translation. Such a correction has been already seen for Tli5 (PA3488) 150 the immunity protein of PldA (Tle5a) of P. aeruginosa [11] . In conclusion of this in silico 151 analysis, the two putative immunities may harbor a Sec signal peptide that suggests a 152 periplasmic localization in agreement with Tle3 activity in this compartment. 153
To demonstrate the antibacterial activity of Tle3 and to identify its immunity protein, 154
we developed a heterologous toxicity assay in E. coli on the basis that Tle3 should be toxic 155 when produced in the periplasm of E. coli and that it should be counteracted by the co-156 production of its immunity protein. In order to artificially address Tle3 to the periplasm of E. 157 coli the tle3 sequence has been cloned in frame with the sequence coding the PelB signal 158 peptide on the pET22b vector under a PT7 promoter. PA0259 from ATG1 and PA0261 were 159 respectively cloned in pRSF-DUET, a higher copy-number vector, to allow a maximal co-160 expression with ss-tle3 in the E. coli BL21(DE3) pLysS strain. The correct production and 161 localization of all the recombinant proteins in E. coli has been verified by western blot after 162 cell fractionation (Fig. 2 sup) . The results presented in Figure 1B indicate that whereas the 163 cytoplasmic production of Tle3 was not toxic, Tle3 targeting to the periplasm led to E. coli 164 killing. Moreover while PA0259 had no effect, the coproduction of PA0261 in the periplasm 165 protected the cells against the toxicity of Tle3. We verified that the sole overproduction of 166 PA0259 and PA0261 was not toxic to E. coli. As PA0261 neutralized Tle3 toxicity, we called 167 it "Tli3" for Type VI lipase immunity ( Fig. 1A ). During this study, we observed that the 168 protection conferred by Tli3 coproduction could be sometimes partial and we solved this issue 169 by cloning in tandem tli3 and tle3 on the same plasmid like they are organized on P. 170 aeruginosa genome ( Fig. 1B , line 8). The importance of this genetic link is the proof of the 171 close connection between these two proteins as a pair of toxin-antitoxin. 172 173 Tli3 (PA0261) is the immunity protein of Tle3 174
As the immunities bind specifically their effector, which is suggested by the release of 175 Tle3 toxicity by Tli3, we tested the physical interaction between both proteins by co-176 purification with affinity chromatography ( Fig. 2A) 
. A cytoplasmic Strep-tagged version of 177
Tli3 was engineered by fusing the tag to the mature domain of Tli3, lacking its signal peptide. 178
The recombinant protein was coproduced in E. coli BL21(DE3) pLysS with the cytoplasmic 179
His10-tagged Tle3. The bacterial lysate was loaded to a StrepTactin matrix (see Materials and 180 Methods section), and Tli3 C Strep was eluted with desthibiotin. The presence of Tle3 C His was 181 controlled in the elution fraction with anti-His antibodies. As showed in Fig. 2A , Tle3 C His was 182 found in the eluted fraction only upon coproduction with Tli3 C Strep (left panel). Indeed when 183 produced alone in E. coli Tle3 C His was not purified by affinity chromatography (right panel). 184
As expected for an immunity protein, Tli3 directly interacts with Tle3. 185
To go further into Tli3 characterization we chose to determine its cellular localization 186 in P. aeruginosa. All the immunity proteins identified so far for Tle proteins are localized in 187 the periplasm or associated to the periplasmic side of the outer membrane [11] [12] [13] 29] in order 188 to counteract their cognate toxin. A chromosomally encoded Tli3V5 translational fusion was 189 engineered in order to specifically immunodetect the protein in P. aeruginosa (Supplementary 190 VgrG2b and since the interaction of another Tle with a VgrG in entero-aggregative E. coli 203 (EAEC) was previously delimitated to the C-terminal domain of VgrG [29] , we cloned the 204 sequences encoding the C-terminal extension (domains 1, 2 and 3) and a truncated version 205 harboring only the DUF2345 and the transthyretin-like (TTR) domains (domains 1 and 2) of 206 VgrG2b downstream the T18 and T25 domains ( Fig. 3A) . 207
Unexpectedly the sole interaction revealed by the BACTH assay for Tle3 was with 208 PA0259 ( Fig. 3B ) since only the T18/T25-Tle3 and T18/T25-PA0259 fusion proteins 209 coproduction activated the expression of the reporter gene. This assay did not confirm the 210 interaction between Tle3 and Tli3 observed by copurification, and did not evidence an 211 interaction with VgrG2b. Interestingly Tle3 and PA0259 did not interact anymore when they 212 were fused upstream the T18 and T25 domains suggesting that both proteins interact via their 213 C-terminal domains (Fig. 3A Sup) . To go further in characterizing the interaction between 214
Tle3 and PA0259, we constructed truncated variants taking into account their domain 215 organization ( Fig. 3 A) . We further delimitated the interacting domain of Tle3 to its extreme 216 C-terminus (the DUF3274 domain) since only the truncated T18-Tle3D2 construct still 217 interacts with T25-PA0259 ( Fig. 3C ). We did not find the domain of interaction within 218 PA0259 as none of the DUF2875 domains alone interacts with Tle3 or this may suggest that 219 both of them are required for the interaction (Fig. 3C ). 220
Next, we took advantage of all the constructs we made to test other interactions. The 221 BACTH assay also showed that PA0259 interacts with both forms of the VgrG2b C-terminal 222 extension ( Fig. 3B ). The domain of interaction on VgrG2b is thus at least constituted by the 223 DUF2345 and TTR domains. We also observed that PA0259 at least dimerizes since all the 224 PA0259 constructs interact with each other whatever the orientation of PA0259 ( C-terminus and the TTR domain ( Fig. 4D ), Tla3 C His was not purified by affinity 249 chromatography. Since VgrG2b truncated for the extreme C-terminus still copurified with 250
Tla3 we can exclude that this domain is required for the interaction. This is in line with the 251 BACTH assay that showed an interaction between Tla3 and a truncated VgrG2b consisting in 252 only the DUF2345 and TTR domains (domains 1 and 2, Fig. 3A ). Moreover, the deletion of 253 the TTR domain affecting the copurification, one can conclude that this domain is key for the 254 interaction. Taken together these data confirmed a direct interaction of Tla3 with Tle3 on one 255 side and with VgrG2b on the other side. By taking into account the BACTH data and the 256 copurification with two truncated forms of VgrG2b, the domain of interaction of VgrG2b 257 with Tla3 can be delimitated to the TTR domain. 258
We then analyzed the cellular localization of Tla3 in P. aeruginosa that, according to 259 its interactions with Tle3 and VgrG2b, should be cytoplasmic. As for Tli3, we engineered a 260 chromosomally encoded Tla3V5 translational fusion ( Supplementary Table 1 ). Tla3 was 261 indeed immunodetected in the cytoplasmic fraction ( Fig. 5A ). One could note that in contrast 262 with our first hypothesis suggesting an incorrect start codon for tla3 and our observation of 263 the recombinant protein in the periplasm of E. coli ( Fig. 1 Sup), Tla3 was totally absent from 264 the periplasmic fraction of P. aeruginosa. To strengthen this result, each putative ATG was 265 individually mutated on the chromosome of the PAO1 strain encoding the Tla3V5 translational 266 fusion ( Fig. 5B ). In agreement with its cytoplasmic localization in P. aeruginosa, Tla3 was 267 only produced if the fourth ATG was intact. Accordingly the Tla3 protein synthesized from 268 this ATG is not predicted to possess a N-terminal signal peptide ( Fig. 1 
Sup). In conclusion 269
Tla3 is a cytoplasmic protein synthesized from the annotated translation start 270 (pseudomonas.com) and this localization is in agreement with a role in the targeting of the 271 toxin to the secretion machinery. 272
Next, we asked whether Tla3 is specific for Tle3 or if it can be required for the 273 secretion of other substrates of the H2-T6SS machinery. Since Hcp secretion is the hallmark 274 of a functional secretion system, we studied the secretion of Hcp2b whose gene is upstream 275 line 4), suggesting that Tla3 is specific for the secretion of Tle3 but not for other H2-T6SS 283 proteins. In line with this specific adaptor-toxin pair, Tla3 C Strep did not copurify TplE (Tle4), 284 another antibacterial phospholipase delivered by the H2-T6SS machinery ( Fig. 5D ). 285
Finally as the interaction with a VgrG can suggest that Tla3 is itself a T6SS effector, 286
we studied whether Tla3 is secreted by P. aeruginosa. To this end the rsmA gene was deleted 287 from the PAO1 strain encoding a Tla3V5 translational fusion. Whereas Tla3V5 was better 288 produced upon rsmA deletion ( Fig. 5E ), this did not lead to immunodetection of Tla3V5 in the 289 extracellular medium although Hcp2b was readily observed by Coomassie-blue staining of 290 the same samples. Tla3 is thus not an effector per se. 291
In conclusion the cytoplasmic localization of Tla3 in P. aeruginosa is appropriate with 292 a recruiting role of Tle3 to the H2-T6SS machinery through an interaction with the TTR 293 domain of VgrG2b. Tla3 is not co-secreted with Tle3. Tla3 role seems specific to Tle3 since it 294 is not required for a functional H2-T6SS machinery and does not interact with TplE (Tle4), 295 another H2-T6SS effector. 296 297
Tle3 secretion mechanism 298
In order to study the antibacterial role and the secretion of Tle3 by P. aeruginosa, we 299 performed intra-species bacterial competition assays between P. aeruginosa strains. This 300 consists in studying the survival of prey bacteria lacking the tli3 immunity gene (by CFU 301 counting of antibiotic resistant bacteria) co-cultivated 24 hours at 37°C on plate with various 302 attackers. As immunity genes are essential genes (protection from fratricide intoxication), 303 both toxin and immunity genes have been deleted in order to construct a viable Dtli3Dtle3 304 mutant strain (Supplementary Table 1 ). The figure 6 first confirms the antibacterial function 305 of Tle3 and the immunity role of Tli3 since the growth of the immunity mutant was affected 306 by the WT strain because it cannot resist Tle3 toxicity, while the Dtle3 mutant had no effect 307 ( Fig. 6 compare line 1 with line 2). The use of the DclpV2 strain, a H2-T6SS mutant and of 308
DvgrG2b and Dtla3 mutants allowed to demonstrate that Tle3 is delivered to prey bacteria 309 through the H2-T6SS machinery and confirms that VgrG2b and Tla3 participate in Tle3 310 targeting to the H2-T6SS machinery ( Fig. 6 compare line 1 with lines 4, 5 and 6). Indeed 311
DclpV2, DvgrG2b and Dtla3 mutants had no effect on the immunity mutant growth since they 312 cannot deliver Tle3 into prey bacteria. The complementation in cis of tle3 and tla3 deletions 313 (the mutants have been constructed for this study) restored a WT phenotype ( Fig. 6 compare 314 line 2 with line 3, and line 6 with line 7) this demonstrating no polar effect on downstream 315
genes. Furthermore the introduction of a wild-type copy of tli3 at the attB site on P. 316 aeruginosa chromosome of the Dtli3Dtle3 mutant restores wilt-type competition capacity to 317 this strain ( Fig. 4A Sup) . This confirms that the absence of the immunity was responsible of 318 the phenotypes observed for the Dtli3Dtle3 strain ( Fig. 6 ). Finally, the Dtla3 mutant has been 319 used as a prey and was not affected by the WT strain or any of the mutants excluding 320 definitively a role of immunity as proposed by its annotation (Pseudomonas.com) and 321 confirming its adaptor function ( Fig. 4B Sup) . 322
Taken together these results demonstrated that Tle3 is an effective H2-T6SS-323 dependent antibacterial toxin loaded onto the VgrG2b puncturing device via Tla3 and 324 neutralized by Tli3 in resistant prey bacteria. 325 326
VgrG2b is a trans-kingdom toxin 327
A putative neutral zinc metallopeptidase domain has been predicted at the extreme C-328 terminus of VgrG2b by Pukatzki and colleagues [34] (Fig. 3A ). This motif (Prosite PS00142, 329 PFAM04298) consists in a metal-binding consensus motif HExxH, the two histidine residues 330 being ligands of the catalytic Zn 2+ and the glutamic acid residue involved in nucleophilic 331 attack. As an effector with a protease activity can target both eukaryotic and bacterial proteins, 332
we searched for an antibacterial activity of the VgrG2b C-terminal extension. To do this we 333 performed the same heterologous toxicity assay in E. coli as with Tle3. As shown in figure 7 , 334
whereas the production of VgrG2bCter in the cytoplasm did not impact E. coli growth, its 335 periplasmic production killed E. coli (Fig. 7 Here we report the existence of a novel pair of antibacterial effector and immunity of 341 the H2-T6SS of P. aeruginosa, Tle3 (PA0260) and Tli3 (PA0261), and we propose a 342 chronology of Tle3 secretion process that includes a cytoplasmic adaptor protein, Tla3 343 (PA0259) to load the toxin onto the VgrG2b spike (a model is proposed in Fig. 8 ). Through 344 heterologous toxicity assay and bacterial competition, we show that Tle3 was toxic once 345 delivered in the periplasm of prey bacteria and that Tli3 can neutralize the toxin in this 346 compartment. Interestingly this led us to discover that VgrG2b that we previously recognized 347 as an anti-eukaryotic effector possesses an antibacterial activity as well. 348
The VgrG-recruitment of cargo effectors has been previously evidenced for several 349 antibacterial effectors among them two toxins of the Tle family, TseL (Tle2) of V. cholerae 350 [16, 17, 35] and Tle1 of EAEC [29] . In both cases the tle genes were just downstream the vgrG 351 genes like the organization of vgrG2b and tle3 of P. aeruginosa. TseL and Tle1 have been 352 shown to directly bind a dedicated VgrG, VgrG3 and VgrG1 respectively [29, 35] (Fig. 3A) that are both required for the interaction with the toxin. 378
Moreover genes coding DUF2875 containing proteins can be find at the vicinity of tle, tli, 379 vgrG or PAAR genes, but they are restricted to a and b proteobacteria (Fig. Sup 5) . We thus 380 hypothesize that DUF2875 might assist in T6SS-mediated effector delivery. Like the three 381 other adaptor families (DUF4123, DUF1795, DUF2169), we have observed that Tla3 is not 382 required for the H2-T6SS functionality since the Dtla3 mutant still secrete Hcp2b and can 383 compete with a WT strain, and that Tla3 is specific for the Tle3 toxin since it did not interact 384 with another H2-T6SS effector, TplE (Tle4). Finally as we did not detect Tla3 secretion under 385 constitutive H2-T6SS condition, we propose that Tla3 hands over Tle3 to VgrG2b in the 386 cytoplasm prior to its loading to the baseplate and further recruitment to the central Hcp tube 387 in preparation (Fig. 8) . Overall, the existence of various modes of effector recruitment, further 388 refined with adaptors, likely explains how the T6SS is able to deliver numerous and 389 structurally diverse proteins. bodies. In the future we will decipher the enzymatic activity of Tle3, which is presumably 402 active on membrane phospholipids as our preliminary data of thin-layer chromotography tend 403 to show. 404
The periplasmic activity of Tle toxins is counteracted by the synthesis of a cognate 405 immunity protein that is usually a periplasmic soluble protein, as we showed for Tli3 in P. 406 aeruginosa, or a membrane-anchored lipoprotein [11] . Interestingly the genetic organization 407 of the tli3 gene upstream of the tle3 gene observed in E. coli, K. pneumoniae, B. cenocepacia 408 or R. solanacearum [11] is conserved in P. aeruginosa. The fact that the two genes are co-409 transcribed (the immunity being the first) is key for the protection against toxicity. Indeed we 410 have observed systematic protection against the periplasmic toxicity of Tle3 in E. coli when 411 the two genes were expressed from the same promoter under the same plasmid whereas it was 412 not as efficient when the genes were on two plasmids. This genetic link reinforces the 413 connection within the toxin/immunity pair. This has previously been noticed with a T7SS 414 antibacterial toxin and its immunity in Staphylococcus aureus [41] . Other immunities of Tle 415 characterized so far have been shown to inhibit the action of the effector by direct protein-416 protein contacts [11, 12, 29] . Our copurification assay in E. coli demonstrates a direct 417 interaction between Tle3 and Tli3 that was already suggested with the release of Tle3 toxicity 418 upon coproduction of Tli3 in the periplasm. A crystal structure of the P. aeruginosa TplE 419 (Tle4) effector in complex with its immunity protein TplEI (Tli4) revealed that the immunity 420 uses a grasp mechanism to prevent the interfacial activation of the toxin [30] . 421
Like two other H2-T6SS related orphan vgrG loci, the vgrG4b cluster encoding PldA 422 (Tle5a) and the vgrG2a encoding TplE (Tle4), we show here that the vgrG2b cluster has both 423 antibacterial activities (through Tle3 and VgrG2b) and anti-eukaryotic (through VgrG2b; 424
[26]). Interestingly VgrG2b is thus (i) a structural component of the H2-T6SS puncturing 425 device since our bacterial competition showed its requirement for Tle3 delivery, (ii) an anti-426 eukaryotic effector through an interaction with the microtubule nucleating complex [26] and 427 (iii) an antibacterial effector as suggested by our toxicity assay in E.coli. We have shown that 428 two conserved residues of the putative metallopeptidase motif (an histidine and a glutamic 429 acid) are essential for the VgrG2b antibacterial activity. This is consistent with an 430 antibacterial protease activity for VgrG2b that will be, to our knowledge, the first case in the 431 T6SS effector literature. The discovery of the VgrG2b immunity is even more exciting. Could 432 it share Tli3 with Tle3? We also hypothesize that an auto-immunity mechanism could exist in 433 which an immunity domain within VgrG2b could be released upon auto-processing liberating 434 the active protease domain like the Serine protease autotransporter proteins. 435
Materials and Methods
437
Bacterial strains, growth conditions and plasmid construction 438
All P. aeruginosa and E. coli strains used in this study are described in 439 Supplementary Table 1 . Briefly, the E. coli K-12 DH5a and CC118lPir were used for 440 cloning procedures. The BL21(DE3)pLysS and BTH101 were used for protein production 441 and BACTH analyses respectively. Strains were grown in LB or in TSB medium (for P. 442 aeruginosa) at 37°C or 30°C. Specific growth conditions are specified in the text when 443 necessary. Recombinant plasmids were introduced into P. aeruginosa by triparental mating 444 using the conjugative properties of the helper plasmid pRK2013 (Supplementary Table 1 ). 445
Plasmids were maintained by the addition of ampicillin (50 µg/mL), kanamycin (50 µg/mL), 446 chloramphenicol (30 µg/mL), streptomycin (30 µg/mL for E. coli, 2000 µg/mL for P. 447 aeruginosa) or gentamicin (30 µg/mL for E. coli, 115 µg/mL for P. aeruginosa). Expression 448 of genes from pT7 in BL21(DE3)pLysS was blocked with 0.4% of glucose and induced in 449 exponential phase (OD600= 0.4-0.6) for 3 hours with 1mM of IPTG. Cloning procedures were 450 described in [26] . The plasmids used and constructed are described in Supplementary Table 1 , 451 the list of oligonucleotides (synthesized by Eurogentec or IDT) is given in Supplementary 452 
Bacterial two-Hybrid Assay 470
Protein-protein interactions were assessed with the adenylate cyclase-based two-471 hybrid technique using protocols published previously [43, 44] . Briefly, the proteins to be 472 tested were fused to the isolated T18 and T25 catalytic domains of the Bordetella adenylate 473 cyclase. After introduction of the two plasmids producing the fusion proteins into the reporter 474 BTH101 strain, plates were incubated at 30°C for 24 h. Three independent colonies for each 475 transformation were inoculated into 600 µl of LB medium supplemented with ampicillin (50 476 µg/mL), kanamycin (50 µg/mL), and IPTG (0.5 mM). After overnight growth at 30 °C, 5 µl 477 of each culture was spotted onto LB agar plates supplemented with ampicillin, kanamycin, 478 IPTG, and 5-bromo-4-chloro-3-indonyl-D-galactopyrannoside (X-gal, 40µg/mL) and 479 incubated for 16 h at 30 °C. Fractionation of cells into spheroplasts (cytoplasm and membranes) and periplasmic 498 fractions were done as previously described [45] . Proteins corresponding to the cytoplasm and 499 periplasm fractions or to insoluble material were resuspended in loading buffer. 500 501 Protein secretion 502 P. aeruginosa strains were grown at 25°C in TBS for 24 hours. Cells corresponding to 503 10 units DO600 and extracellular medium were separated by centrifugation at 2000 x g for 10 504 min at room temperature. 2/3 of the supernatants were collected and centrifuged at 13 000 x g 505 for 5 min at room temperature. Proteins contained in the supernatant were precipitated with 506 tricholoro-acetic acid (TCA, 15%) for 3 h at 4°C. Samples were centrifuged at 13 000 x g for 507 30 min at 4°C, pellets washed with 90% acetone and resuspended in loading buffer. 508
509
SDS-PAGE and western-blot 510
Protein samples derived from equivalent amounts of culture (i.e. optical density 511 equivalents) resuspended in loading buffer were boiled and separated by SDS-PAGE. 512
Proteins were then stained by Coomassie-blue or immunodetected as described before [26] 513 using primary polyclonal antibodies directed against His6 epitope-tag (Penta His, Qiagen, 514 towards the target bacterium. Tle3 associated with this expelled structure is thus translocated 801 into target cells, as well as VgrG2bCter (green circle). The prey is killed (Prey S ) except if it has 802 the Tli3 immunity (in blue) in the periplasm (Prey R ). The mechanism of resistance to 803 
